BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35698180)

  • 61. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer.
    Wikberg ML; Ling A; Li X; Öberg Å; Edin S; Palmqvist R
    Hum Pathol; 2017 Oct; 68():193-202. PubMed ID: 28882699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
    Wen S; He L; Zhong Z; Mi H; Liu F
    Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals.
    Zhou C; Xiao W; Wang X; Chen H; Niu S; Wang Q; Chang H; Wu X; Ding P; Pan Z; Wan X; Bao Y; Gao Y
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1145-1155. PubMed ID: 32968876
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of a novel macrophage-related prognostic signature in colorectal cancer.
    Lin D; Zheng T; Huang S; Liu R; Guan S; Zhang Z
    Sci Rep; 2024 Feb; 14(1):2767. PubMed ID: 38307957
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
    Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
    Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
    Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and Survival.
    Taylor CC; Millien VO; Hou JK; Massarweh NN
    J Surg Res; 2020 Mar; 247():77-85. PubMed ID: 31767275
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer.
    Liu Z; Lu T; Wang Y; Jiao D; Li Z; Wang L; Liu L; Guo C; Zhao Y; Han X
    J Cell Mol Med; 2021 Jul; 25(14):6874-6886. PubMed ID: 34101338
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer.
    Li T; Liu W; Wang C; Wang M; Hui W; Lu J; Gao F
    J Immunol Res; 2022; 2022():5164265. PubMed ID: 35310607
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
    Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
    BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
    Wang Y; Huang L; Shan N; Ma H; Lu S; Chen X; Long H
    Aging (Albany NY); 2021 Aug; 13(15):19894-19907. PubMed ID: 34388112
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
    Ou B; Zhao J; Guan S; Lu A
    Dig Dis Sci; 2016 Mar; 61(3):881-9. PubMed ID: 26518415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
    Svrcek M; El-Bchiri J; Chalastanis A; Capel E; Dumont S; Buhard O; Oliveira C; Seruca R; Bossard C; Mosnier JF; Berger F; Leteurtre E; Lavergne-Slove A; Chenard MP; Hamelin R; Cosnes J; Beaugerie L; Tiret E; Duval A; Fléjou JF
    J Clin Oncol; 2007 Sep; 25(27):4231-8. PubMed ID: 17878476
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
    Yu J; Yang K; Zheng J; Sun X; Zhao W
    Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
    Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
    Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.